Whole-genome sequencing has been used to demonstrate that carbapenem resistance can be transferred among unrelated bacteria species in a healthcare setting.
Browsing: Bacterial > E. Coli
Researchers have discovered a high prevalence of colistin-resistant E. coli in the Vietnamese town of Nguyen Xa, according to research presented at ASM Microbe.
In research presented at ASM Microbe a team have delved into the dynamics of E. coli in urban streams in the USA, indicating possible antibiotic resistance activity.
Research presented at ECCMID outlines the identification and role of novel chromosomal mutations in the development of resistance of Escherichia coli to the broad-spectrum antibiotic fosfomycin.
The results of the MERINO trial have been reported at ECCMID, revealing the combination treatment piperacillin-tazobactam is significantly less effective than meropenem in treating some bloodstream infections.
E. coli’s internal bomb – the toxin-antitoxin system – could be triggered to make bacteria turn on themselves, offering a new target for antimicrobial approaches in drug design.
Partnership announcements and promising trial data reported at the 2018 Conference on Retroviruses and Opportunistic Infections, take a look at our round-up of the latest industry headlines.
The WHO has released its first surveillance data on antibiotic resistance, revealing that it is widespread across both low-income and high-income countries.
This research, published in Future Microbiology, screens host proteins for those that interact with EspF via flow cytometry and high-throughput screening to try and shed light on how EspF affects host cells to induce colitis and even colorectal carcinogenesis.
In a recent study published in Nature Communications, researchers demonstrated that acquired resistance to the polymixin antibiotic, colistin, can be detrimental to bacterial survival, revealing unique evolutionary trade-offs of this new form of resistance.